Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria
Clinical trial NCT07378527 · RECRUITING
Trial details
- NCT number
- NCT07378527
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-13
- Primary completion
- 2028-09-01
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.